HomeCAPS • NASDAQ
Capstone Therapeutics Corp
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | 2023info | Y/Y change |
|---|---|---|
Revenue | 48.35M | -21.45% |
Operating expense | 10.87M | -13.33% |
Net income | -3.82M | -264.97% |
Net profit margin | -7.90 | -310.11% |
Earnings per share | — | — |
EBITDA | -950.00K | -122.44% |
Effective tax rate | -6.53% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 52.00K | 126.09% |
Total assets | 52.70M | -19.19% |
Total liabilities | 23.58M | -26.04% |
Total equity | 29.12M | — |
Shares outstanding | 157.61K | — |
Price to book | 0.15 | — |
Return on assets | -1.33% | — |
Return on capital | -1.41% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | 2023info | Y/Y change |
|---|---|---|
Net income | -3.82M | -264.97% |
Cash from operations | 1.45M | 150.14% |
Cash from investing | -208.00K | -20.23% |
Cash from financing | -1.21M | -139.95% |
Net change in cash | 28.00K | 203.70% |
Free cash flow | 2.45M | 165.83% |
Previous close
$2.36
Day range
$2.00 - $2.24
Year range
$1.72 - $4.18
Market cap
10.48M USD
Avg Volume
674.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1987
Headquarters
Website
Employees
38
